Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

I can assure you if the LN trial results are not good enough, Aurinia is a fail. VOC is for an indication where there are no approved compounds, where VOS for dry eye has a ton of competition.

One of the analysts on the recent call brought up a very important detail that I hope you didn’t miss. He asked Neil how do you control and know if the patients are tapering the steroids per the trial protocol. Neil, as he usually does, bumbled the answer and basically didn’t answer the question. They are relying on the patients tapering the steroids. This is a risky element to the trial as most people can’t remember to take their vitamins every day let alone taking a dose that changes regularly.